145 related articles for article (PubMed ID: 24115678)
1. Rituximab as therapy for the recurrence of bile salt export pump deficiency after liver transplantation.
Lin HC; Alvarez L; Laroche G; Melin-Aldana H; Pfeifer K; Schwarz K; Whitington PF; Alonso EM; Ekong UD
Liver Transpl; 2013 Dec; 19(12):1403-10. PubMed ID: 24115678
[TBL] [Abstract][Full Text] [Related]
2. Cholestasis After Pediatric Liver Transplantation-Recurrence of a Progressive Familial Intrahepatic Cholestasis Phenotype as a Rare Differential Diagnosis: A Case Report.
Prusinskas B; Kathemann S; Pilic D; Hegen B; Küster P; Keitel V; Häussinger D; Büscher R; Baba HA; Hoyer PF; Lainka E
Transplant Proc; 2017 Sep; 49(7):1628-1633. PubMed ID: 28838453
[TBL] [Abstract][Full Text] [Related]
3. Recurrence of Progressive Familial Intrahepatic Cholestasis Type 2 Phenotype After Living-donor Liver Transplantation: A Case Report.
Masahata K; Uehara S; Ibuka S; Nakahata K; Hasegawa Y; Kondou H; Kubitz R; Ueno T
Transplant Proc; 2016 Nov; 48(9):3156-3162. PubMed ID: 27932171
[TBL] [Abstract][Full Text] [Related]
4. Relapsing features of bile salt export pump deficiency after liver transplantation in two patients with progressive familial intrahepatic cholestasis type 2.
Maggiore G; Gonzales E; Sciveres M; Redon MJ; Grosse B; Stieger B; Davit-Spraul A; Fabre M; Jacquemin E
J Hepatol; 2010 Nov; 53(5):981-6. PubMed ID: 20800306
[TBL] [Abstract][Full Text] [Related]
5. De novo bile salt transporter antibodies as a possible cause of recurrent graft failure after liver transplantation: a novel mechanism of cholestasis.
Keitel V; Burdelski M; Vojnisek Z; Schmitt L; Häussinger D; Kubitz R
Hepatology; 2009 Aug; 50(2):510-7. PubMed ID: 19642168
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune BSEP disease: disease recurrence after liver transplantation for progressive familial intrahepatic cholestasis.
Kubitz R; Dröge C; Kluge S; Stross C; Walter N; Keitel V; Häussinger D; Stindt J
Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):273-84. PubMed ID: 25342496
[TBL] [Abstract][Full Text] [Related]
7. Bile salt export pump-reactive antibodies form a polyclonal, multi-inhibitory response in antibody-induced bile salt export pump deficiency.
Stindt J; Kluge S; Dröge C; Keitel V; Stross C; Baumann U; Brinkert F; Dhawan A; Engelmann G; Ganschow R; Gerner P; Grabhorn E; Knisely AS; Noli KA; Pukite I; Shepherd RW; Ueno T; Schmitt L; Wiek C; Hanenberg H; Häussinger D; Kubitz R
Hepatology; 2016 Feb; 63(2):524-37. PubMed ID: 26516723
[TBL] [Abstract][Full Text] [Related]
8. Post-transplant Recurrent Bile Salt Export Pump Disease: A Form of Antibody-mediated Graft Dysfunction and Utilization of C4d.
Patel KR; Harpavat S; Finegold M; Eldin K; Hicks J; Firan M; Keitel V; Kubitz R; Wu H
J Pediatr Gastroenterol Nutr; 2017 Oct; 65(4):364-369. PubMed ID: 28945205
[TBL] [Abstract][Full Text] [Related]
9. High affinity anti-BSEP antibodies after liver transplantation for PFIC-2 - Successful treatment with immunoadsorption and B-cell depletion.
Kubitz R; Dröge C; Kluge S; Stindt J; Stross C; Häussinger D; Flechtenmacher C; Wenning D; Teufel U; Schmitt CP; Engelmann G
Pediatr Transplant; 2016 Nov; 20(7):987-993. PubMed ID: 27368585
[TBL] [Abstract][Full Text] [Related]
10. Progressive familial intrahepatic cholestasis.
Jacquemin E
Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S26-35. PubMed ID: 23141890
[TBL] [Abstract][Full Text] [Related]
11. Iterative antibody-induced bile salt export pump deficiency after successive liver transplantations successfully treated with plasmapheresis and rituximab.
Wischlen E; Laverdure N; Erard D; Rohmer B; Boillot O; Dubois R; Lachaux A; Collardeau-Frachon S; Hervieu V; Dumortier J
Clin Res Hepatol Gastroenterol; 2023 May; 47(6):102139. PubMed ID: 37187258
[TBL] [Abstract][Full Text] [Related]
12. ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history.
Davit-Spraul A; Fabre M; Branchereau S; Baussan C; Gonzales E; Stieger B; Bernard O; Jacquemin E
Hepatology; 2010 May; 51(5):1645-55. PubMed ID: 20232290
[TBL] [Abstract][Full Text] [Related]
13. Recurrent low gamma-glutamyl transpeptidase cholestasis following liver transplantation for bile salt export pump (BSEP) disease (posttransplant recurrent BSEP disease).
Siebold L; Dick AA; Thompson R; Maggiore G; Jacquemin E; Jaffe R; Strautnieks S; Grammatikopoulos T; Horslen S; Whitington PF; Shneider BL
Liver Transpl; 2010 Jul; 16(7):856-63. PubMed ID: 20583290
[TBL] [Abstract][Full Text] [Related]
14. Alloimmunity and Cholestasis After Liver Transplantation in Children With Progressive Familial Intrahepatic Cholestasis.
Krebs-Schmitt D; Briem-Richter A; Brinkert F; Keitel V; Pukite I; Lenhartz H; Fischer L; Grabhorn E
J Pediatr Gastroenterol Nutr; 2019 Feb; 68(2):169-174. PubMed ID: 30664572
[TBL] [Abstract][Full Text] [Related]
15. Recurrence of bile salt export pump deficiency after liver transplantation.
Jara P; Hierro L; Martínez-Fernández P; Alvarez-Doforno R; Yánez F; Diaz MC; Camarena C; De la Vega A; Frauca E; Muñoz-Bartolo G; López-Santamaría M; Larrauri J; Alvarez L
N Engl J Med; 2009 Oct; 361(14):1359-67. PubMed ID: 19797282
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic differences in PFIC2 and BRIC2 correlate with protein stability of mutant Bsep and impaired taurocholate secretion in MDCK II cells.
Kagawa T; Watanabe N; Mochizuki K; Numari A; Ikeno Y; Itoh J; Tanaka H; Arias IM; Mine T
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G58-67. PubMed ID: 17947449
[TBL] [Abstract][Full Text] [Related]
17. Late-Onset Drug-Induced Cholestasis in a Living-Related Liver Transplant Donor With Progressive Familial Intrahepatic Cholestasis.
Harmancı Ö; Ensaroğlu F; Özçay F; Öcal S; Korkmaz M; Özdemir BH; Selçuk H; Moray G; Haberal M
Exp Clin Transplant; 2015 Nov; 13 Suppl 3():107-9. PubMed ID: 26640927
[TBL] [Abstract][Full Text] [Related]
18. Progressive Familial Intrahepatic Cholestasis Type 2 and Recurrence After Liver Transplantation: A Case Report.
Romeres SGB; Trevizoli NC; Oliveira CAM; Obeid EJ; Arantes Ferreira GS; De Campos PB; Ullmann RFB; Rocha HC; Figueira AVF; Diaz LGG; Jorge FMF; Caja GON; Watanabe ALC; Sobroza de Mello E; Carvalho E
Transplant Proc; 2022 Jun; 54(5):1370-1375. PubMed ID: 35718560
[TBL] [Abstract][Full Text] [Related]
19. Short-chain ubiquitination is associated with the degradation rate of a cell-surface-resident bile salt export pump (BSEP/ABCB11).
Hayashi H; Sugiyama Y
Mol Pharmacol; 2009 Jan; 75(1):143-50. PubMed ID: 18829893
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
